Bausch + Lomb Appoints Thomas J. Appio as Interim Chief Executive Officer
Bausch + Lomb Corporation and its parent company, Bausch Health Companies Inc announced that Bausch…
Bausch + Lomb Advances Novel Oral Treatment for Dry AMD Following Constructive FDA Meeting
Bausch + Lomb Corporation announced progress in the development of BL1243 (tonabersat), an investigational oral…
Bausch + Lomb Review Examines Artificial Tear Selection for Personalized Dry Eye Management
Bausch + Lomb announced the publication of a comprehensive review article examining tear film structure…



